Here, we focused on the ATP6V0a3 (a3) subunit, which was proposed to target the V-ATPase to the plasma membrane in some invasive breast cancer and melanoma cells [20,21,22] and was previously detected in the plasma membrane of PDAC cells [27]. This evidence concerns the gene TCIRG1 and invasive breast carcinoma.